Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Tuberculosis recurrence in a high incidence setting for HIV and tuberculosis in Brazil

Authors: Gisela Unis, Andrezza Wolowski Ribeiro, Leonardo Souza Esteves, Fernanda Sá Spies, Pedro Dornelles Picon, Elis Regina Dalla Costa, Maria Lucia Rosa Rossetti

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

To compare epidemiological data between recurrent cases after cure (RC), distinguishing relapse from reinfection, after dropout (RD) and new cases (NC) in an ambulatory setting in a TB-endemic country.

Methods

Records of patients who started treatment for pulmonary TB between 2004 and 2010 in a TB clinic were reviewed. Epidemiological data were analyzed. Spoligotyping and MIRU patterns were used to determine relapse or reinfection in 13 RC available.

Results

Of the eligible group (1449), 1060 were NC (73.2%), among the recurrent cases, 203 (14%) were RC and 186 (12.8%) were RD. Of RC, 171 (84.2%) occurred later than 6 months after a previous episode, 13 had available DNA, in 4 (30.7%) the disease was attributed to reinfection and in 9 (69.3%), to relapse. Comparing RC to NC, HIV (p < 0.0001) was independent risk factor for RC. When RC and RD were compared, alcohol abuse (p = 0.001) and treatment noncompliance (p = 0.006) were more frequent in RD.

Conclusions

HIV is the sole more important associated factor for RC. This finding points the need to improve the approach to manage TB in order to decrease the chance for exposure especially in vulnerable people with increased risk of developing disease and to improve DOTS strategy to deal with factors associated to treatment noncompliance.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lambert ML, Hasker E, Van Deun A, Roberfroid D, Boelaert M, Van der Stuyft P: Recurrence in tuberculosis: relapse or reinfection?. Lancet Infect Dis. 2003, 3: 282-287. 10.1016/S1473-3099(03)00607-8.CrossRefPubMed Lambert ML, Hasker E, Van Deun A, Roberfroid D, Boelaert M, Van der Stuyft P: Recurrence in tuberculosis: relapse or reinfection?. Lancet Infect Dis. 2003, 3: 282-287. 10.1016/S1473-3099(03)00607-8.CrossRefPubMed
2.
go back to reference Charalambous S, Grant AD, Moloi V, Warren R, Day JH, van Helden P, Hayes RJ, Fielding KL, De Cock KM, Chaisson RE, Churchyard GJ: Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis. 2008, 12: 942-948.PubMed Charalambous S, Grant AD, Moloi V, Warren R, Day JH, van Helden P, Hayes RJ, Fielding KL, De Cock KM, Chaisson RE, Churchyard GJ: Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis. 2008, 12: 942-948.PubMed
3.
go back to reference Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW, Enarson DA, Behr MA, van Helden PD: Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005, 171: 1430-1435. 10.1164/rccm.200409-1200OC.CrossRefPubMed Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW, Enarson DA, Behr MA, van Helden PD: Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005, 171: 1430-1435. 10.1164/rccm.200409-1200OC.CrossRefPubMed
4.
go back to reference Glynn JR, Murray J, Bester A, Nelson G, Shearer S, Sonnenberg P: High rates of recurrence in HIV-infected and HIV-uninfected patients with tuberculosis. J Infect Dis. 2010, 201: 704-711. 10.1086/650529.CrossRefPubMed Glynn JR, Murray J, Bester A, Nelson G, Shearer S, Sonnenberg P: High rates of recurrence in HIV-infected and HIV-uninfected patients with tuberculosis. J Infect Dis. 2010, 201: 704-711. 10.1086/650529.CrossRefPubMed
5.
go back to reference Golub JE, Durovni B, King BS, Cavalacante SC, Pacheco AG, Moulton LH, Moore RD, Chaisson RE, Saraceni V: Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil. AIDS. 2008, 22: 2527-2533. 10.1097/QAD.0b013e328311ac4e.CrossRefPubMedPubMedCentral Golub JE, Durovni B, King BS, Cavalacante SC, Pacheco AG, Moulton LH, Moore RD, Chaisson RE, Saraceni V: Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil. AIDS. 2008, 22: 2527-2533. 10.1097/QAD.0b013e328311ac4e.CrossRefPubMedPubMedCentral
6.
go back to reference Narayanan S, Swaminathan S, Supply P, Shanmugam S, Narendran G, Hari L, Ramachandran R, Locht C, Jawahar MS, Narayanan PR: Impact of HIV infection on the recurrence of tuberculosis in South India. J Infect Dis. 2010, 201: 691-703. 10.1086/650528.CrossRefPubMed Narayanan S, Swaminathan S, Supply P, Shanmugam S, Narendran G, Hari L, Ramachandran R, Locht C, Jawahar MS, Narayanan PR: Impact of HIV infection on the recurrence of tuberculosis in South India. J Infect Dis. 2010, 201: 691-703. 10.1086/650528.CrossRefPubMed
7.
go back to reference Picon PD, Bassanesi SL, Caramori ML, Ferreira RL, Jarczewski CA, Vieira PR: Risk factors for recurrence of tuberculosis. J Bras Pneumol. 2007, 33: 572-578. 10.1590/S1806-37132007000500013.CrossRefPubMed Picon PD, Bassanesi SL, Caramori ML, Ferreira RL, Jarczewski CA, Vieira PR: Risk factors for recurrence of tuberculosis. J Bras Pneumol. 2007, 33: 572-578. 10.1590/S1806-37132007000500013.CrossRefPubMed
8.
go back to reference Luzze H, Johnson DF, Dickman K, Mayanja-Kizza H, Okwera A, Eisenach K, Cave MD, Whalen CC, Johnson JL, Boom WH, Joloba M: Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda. Int J Tuberc Lung Dis. 2013, 17: 361-367. 10.5588/ijtld.11.0692.CrossRefPubMed Luzze H, Johnson DF, Dickman K, Mayanja-Kizza H, Okwera A, Eisenach K, Cave MD, Whalen CC, Johnson JL, Boom WH, Joloba M: Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda. Int J Tuberc Lung Dis. 2013, 17: 361-367. 10.5588/ijtld.11.0692.CrossRefPubMed
9.
go back to reference Millet JP, Shaw E, Orcau A, Casals M, Miró JM, Caylà JA: Tuberculosis recurrence after completion treatment in a European city: reinfection or relapse?. PLoS One. 2013, 8: e64898-10.1371/journal.pone.0064898.CrossRefPubMedPubMedCentral Millet JP, Shaw E, Orcau A, Casals M, Miró JM, Caylà JA: Tuberculosis recurrence after completion treatment in a European city: reinfection or relapse?. PLoS One. 2013, 8: e64898-10.1371/journal.pone.0064898.CrossRefPubMedPubMedCentral
10.
go back to reference Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G: Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006, 368: 1575-1580. 10.1016/S0140-6736(06)69573-1.CrossRefPubMed Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G: Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006, 368: 1575-1580. 10.1016/S0140-6736(06)69573-1.CrossRefPubMed
11.
go back to reference Marx FM, Dunbar R, Hesseling AC, Enarson DA, Fielding K, Beyers N: Increased risk of default among previously treated tuberculosis cases in the Western Cape Province, South Africa. Int J Tuberc Lung Dis. 2012, 16: 1059-1065. 10.5588/ijtld.11.0506.CrossRefPubMed Marx FM, Dunbar R, Hesseling AC, Enarson DA, Fielding K, Beyers N: Increased risk of default among previously treated tuberculosis cases in the Western Cape Province, South Africa. Int J Tuberc Lung Dis. 2012, 16: 1059-1065. 10.5588/ijtld.11.0506.CrossRefPubMed
12.
go back to reference Programa Nacional de Controle da Tuberculose. Manual de Recomendações para o Controle da Tuberculose no Brasil. 1a ed. 2011, Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde, Brasília Programa Nacional de Controle da Tuberculose. Manual de Recomendações para o Controle da Tuberculose no Brasil. 1a ed. 2011, Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde, Brasília
14.
go back to reference Cafrune PI, Possuelo LG, Ribeiro AW, Ribeiro MO, Unis G, Jarczewski CA, Rossetti ML, Zaha A: Prospective study applying spoligotyping directly to DNA from sputum samples of patients suspected of having tuberculosis. Can J Microbiol. 2009, 55: 895-900. 10.1139/W09-033.CrossRefPubMed Cafrune PI, Possuelo LG, Ribeiro AW, Ribeiro MO, Unis G, Jarczewski CA, Rossetti ML, Zaha A: Prospective study applying spoligotyping directly to DNA from sputum samples of patients suspected of having tuberculosis. Can J Microbiol. 2009, 55: 895-900. 10.1139/W09-033.CrossRefPubMed
15.
go back to reference Perizzolo PF, Dalla Costa ER, Ribeiro AW, Spies FS, Ribeiro MO, Dias CF, Unis G, Almeida da Silva P, Gomes HM, Suffys PN, Rossetti ML: Characteristics of multidrug-resistant Mycobacterium tuberculosis in southern Brazil. Tuberculosis (Edinb). 2012, 92: 56-59. 10.1016/j.tube.2011.09.008.CrossRef Perizzolo PF, Dalla Costa ER, Ribeiro AW, Spies FS, Ribeiro MO, Dias CF, Unis G, Almeida da Silva P, Gomes HM, Suffys PN, Rossetti ML: Characteristics of multidrug-resistant Mycobacterium tuberculosis in southern Brazil. Tuberculosis (Edinb). 2012, 92: 56-59. 10.1016/j.tube.2011.09.008.CrossRef
16.
go back to reference Dalla Costa ER, Lazzarini LC, Perizzolo PF, Díaz CA, Spies FS, Costa LL, Ribeiro AW, Barroco C, Schuh SJ, da Silva Pereira MA, Dias CF, Gomes HM, Unis G, Zaha A, Almeida da Silva PE, Suffys PN, Rossetti ML: Mycobacterium tuberculosis of the RDRio genotype is the predominant cause of tuberculosis and associated with multidrug resistance in Porto Alegre City, South Brazil. J Clin Microbiol. 2013, 51: 1071-1077. 10.1128/JCM.01511-12.CrossRefPubMedPubMedCentral Dalla Costa ER, Lazzarini LC, Perizzolo PF, Díaz CA, Spies FS, Costa LL, Ribeiro AW, Barroco C, Schuh SJ, da Silva Pereira MA, Dias CF, Gomes HM, Unis G, Zaha A, Almeida da Silva PE, Suffys PN, Rossetti ML: Mycobacterium tuberculosis of the RDRio genotype is the predominant cause of tuberculosis and associated with multidrug resistance in Porto Alegre City, South Brazil. J Clin Microbiol. 2013, 51: 1071-1077. 10.1128/JCM.01511-12.CrossRefPubMedPubMedCentral
17.
go back to reference Canetti G, Rist N, Grosset J: Measurement of sensitivity of the tuberculosis bacillus to antibacillary drugs by the method of proportions: methodology, resistance criteria, results, and interpretation. Rev Tuberc Pneumol. 1963, 27: 217-272. Canetti G, Rist N, Grosset J: Measurement of sensitivity of the tuberculosis bacillus to antibacillary drugs by the method of proportions: methodology, resistance criteria, results, and interpretation. Rev Tuberc Pneumol. 1963, 27: 217-272.
18.
go back to reference van Soolingen D, de Haas PE, Hermans PW, van Embden JD: DNA fingerprinting of Mycobacterium tuberculosis. Methods Enzymol. 1994, 235: 196-205. 10.1016/0076-6879(94)35141-4.CrossRefPubMed van Soolingen D, de Haas PE, Hermans PW, van Embden JD: DNA fingerprinting of Mycobacterium tuberculosis. Methods Enzymol. 1994, 235: 196-205. 10.1016/0076-6879(94)35141-4.CrossRefPubMed
19.
go back to reference Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J: Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997, 35: 907-914.PubMedPubMedCentral Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J: Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997, 35: 907-914.PubMedPubMedCentral
20.
go back to reference Demay C, Liens B, Burguière T, Hill V, Couvin D, Millet J, Mokrousov I, Sola C, Zozio T, Rastogi N: SITVITWEB-a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol. 2012, 12: 755-766. 10.1016/j.meegid.2012.02.004.CrossRefPubMed Demay C, Liens B, Burguière T, Hill V, Couvin D, Millet J, Mokrousov I, Sola C, Zozio T, Rastogi N: SITVITWEB-a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol. 2012, 12: 755-766. 10.1016/j.meegid.2012.02.004.CrossRefPubMed
21.
go back to reference Korenromp EL, Scano F, Williams BG, Dye C, Nunn P: Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clin Infect Dis. 2003, 37: 101-112. 10.1086/375220.CrossRefPubMed Korenromp EL, Scano F, Williams BG, Dye C, Nunn P: Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clin Infect Dis. 2003, 37: 101-112. 10.1086/375220.CrossRefPubMed
22.
go back to reference Pettit AC, Kaltenbach LA, Maruri F, Cummins J, Smith TR, Warkentin JV, Griffin MR, Sterling TR: Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting. Int J Tuberc Lung Dis. 2011, 15: 906-911. 10.5588/ijtld.10.0448.CrossRefPubMedPubMedCentral Pettit AC, Kaltenbach LA, Maruri F, Cummins J, Smith TR, Warkentin JV, Griffin MR, Sterling TR: Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting. Int J Tuberc Lung Dis. 2011, 15: 906-911. 10.5588/ijtld.10.0448.CrossRefPubMedPubMedCentral
23.
go back to reference Nunn AJ, Phillips PP, Mitchison DA: Timing of relapse in short-course chemotherapy trials for tuberculosis. Int J Tuberc Lung Dis. 2010, 14: 241-242.PubMed Nunn AJ, Phillips PP, Mitchison DA: Timing of relapse in short-course chemotherapy trials for tuberculosis. Int J Tuberc Lung Dis. 2010, 14: 241-242.PubMed
24.
go back to reference de Boer AS, Borgdorff MW, Vynnycky E, Sebek MM, van Soolingen D: Exogenous re-infection as a cause of recurrent tuberculosis in a low-incidence area. Int J Tuberc Lung Dis. 2003, 7: 145-152.PubMed de Boer AS, Borgdorff MW, Vynnycky E, Sebek MM, van Soolingen D: Exogenous re-infection as a cause of recurrent tuberculosis in a low-incidence area. Int J Tuberc Lung Dis. 2003, 7: 145-152.PubMed
25.
go back to reference Pulido F, Peña JM, Rubio R, Moreno S, González J, Guijarro C, Costa JR, Vázquez JJ: Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients. Arch Intern Med. 1997, 157: 227-232. 10.1001/archinte.1997.00440230105014.CrossRefPubMed Pulido F, Peña JM, Rubio R, Moreno S, González J, Guijarro C, Costa JR, Vázquez JJ: Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients. Arch Intern Med. 1997, 157: 227-232. 10.1001/archinte.1997.00440230105014.CrossRefPubMed
26.
go back to reference Chang KC, Leung CC, Yew WW, Ho SC, Tam CM: A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med. 2004, 170: 1124-1130. 10.1164/rccm.200407-905OC.CrossRefPubMed Chang KC, Leung CC, Yew WW, Ho SC, Tam CM: A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med. 2004, 170: 1124-1130. 10.1164/rccm.200407-905OC.CrossRefPubMed
27.
go back to reference Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P: HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001, 358: 1687-1693. 10.1016/S0140-6736(01)06712-5.CrossRefPubMed Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P: HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001, 358: 1687-1693. 10.1016/S0140-6736(01)06712-5.CrossRefPubMed
28.
go back to reference Panjabi R, Comstock GW, Golub JE: Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis. 2007, 11: 828-837.PubMed Panjabi R, Comstock GW, Golub JE: Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis. 2007, 11: 828-837.PubMed
29.
go back to reference Crampin AC, Mwaungulu JN, Mwaungulu FD, Mwafulirwa DT, Munthali K, Floyd S, Fine PE, Glynn JR: Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS. 2010, 24: 417-426. 10.1097/QAD.0b013e32832f51cf.CrossRefPubMedPubMedCentral Crampin AC, Mwaungulu JN, Mwaungulu FD, Mwafulirwa DT, Munthali K, Floyd S, Fine PE, Glynn JR: Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS. 2010, 24: 417-426. 10.1097/QAD.0b013e32832f51cf.CrossRefPubMedPubMedCentral
30.
go back to reference Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, Selvakumar N, Ganapathy S, Charles N, Rajamma J, Narayanan PR: Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis. 2002, 6: 780-788.PubMed Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, Selvakumar N, Ganapathy S, Charles N, Rajamma J, Narayanan PR: Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis. 2002, 6: 780-788.PubMed
31.
go back to reference Jaggarajamma K, Sudha G, Chandrasekaran V, Nirupa C, Thomas A, Santha T, Muniyandi M, Narayanan PR: Reasons for non-compliance among patients treated under Revised National Tuberculosis Control Programme (RNTCP), Tiruvallur district, south India. Indian J Tuberc. 2007, 54: 130-135.PubMed Jaggarajamma K, Sudha G, Chandrasekaran V, Nirupa C, Thomas A, Santha T, Muniyandi M, Narayanan PR: Reasons for non-compliance among patients treated under Revised National Tuberculosis Control Programme (RNTCP), Tiruvallur district, south India. Indian J Tuberc. 2007, 54: 130-135.PubMed
32.
go back to reference Vijay S, Kumar P, Chauhan LS, Vollepore BH, Kizhakkethil UP, Rao SG: Risk factors associated with default among new smear positive TB patients treated under DOTS in India. PLoS One. 2010, 5: e10043-10.1371/journal.pone.0010043.CrossRefPubMedPubMedCentral Vijay S, Kumar P, Chauhan LS, Vollepore BH, Kizhakkethil UP, Rao SG: Risk factors associated with default among new smear positive TB patients treated under DOTS in India. PLoS One. 2010, 5: e10043-10.1371/journal.pone.0010043.CrossRefPubMedPubMedCentral
33.
go back to reference Chirinos NEC, Meirelles BHS: Fatores associados ao abandono do tratamento da tuberculose: uma revisão integrativa. Texto contexto - enferm. 2011, 20: 599-606. 10.1590/S0104-07072011000300023.CrossRef Chirinos NEC, Meirelles BHS: Fatores associados ao abandono do tratamento da tuberculose: uma revisão integrativa. Texto contexto - enferm. 2011, 20: 599-606. 10.1590/S0104-07072011000300023.CrossRef
34.
go back to reference Das S, Chan SL, Allen BW, Mitchison DA, Lowrie DB: Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy. Tuber Lung Dis. 1993, 74: 47-51. 10.1016/0962-8479(93)90068-9.CrossRefPubMed Das S, Chan SL, Allen BW, Mitchison DA, Lowrie DB: Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy. Tuber Lung Dis. 1993, 74: 47-51. 10.1016/0962-8479(93)90068-9.CrossRefPubMed
35.
go back to reference Quy HT, Cobelens FG, Lan NT, Buu TN, Lambregts CS, Borgdorff MW: Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis. 2006, 10: 45-51.PubMed Quy HT, Cobelens FG, Lan NT, Buu TN, Lambregts CS, Borgdorff MW: Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis. 2006, 10: 45-51.PubMed
Metadata
Title
Tuberculosis recurrence in a high incidence setting for HIV and tuberculosis in Brazil
Authors
Gisela Unis
Andrezza Wolowski Ribeiro
Leonardo Souza Esteves
Fernanda Sá Spies
Pedro Dornelles Picon
Elis Regina Dalla Costa
Maria Lucia Rosa Rossetti
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-014-0548-6

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.